FMR LLC

Position in CLYM — Climb Bio, Inc.

CIK 315066 BOSTON, MA

Position in CLYM

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$88,546,345

+$88,502,526 QoQ

Shares Held

6,790,364

+106049.2% QoQ

Ownership

11.8%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 108 holders

Holding Since

Mar 2022

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FMR LLC holds $61,424,667,384 across 370 Biotechnology names. CLYM ranks #101 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	5,231,452	$4,853,584,218
2	ALNY	Alnylam Pharmaceuticals, Inc.	15,023,962	$4,522,663,276
3	MRNA	Moderna, Inc.	51,859,891	$3,631,748,165
4	ROIV	Roivant Sciences Ltd.	81,020,390	$2,867,311,601
5	RVMD	Revolution Medicines, Inc.	12,200,422	$2,284,895,029
6	IONS	Ionis Pharmaceuticals Inc	24,631,956	$1,953,067,789
7	INSM	INSMED Inc	16,143,583	$1,721,228,815
8	KRYS	Krystal Biotech, Inc.	4,418,197	$1,642,111,277

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$88,546,346	6,790,364	—	Shares	Sole	2026-07-08
2026-06-30	$88,546,345	6,790,364	+106049.2%	Shares	Defined	2026-08-13
2026-03-31	$43,819	6,397	+0.8%	Shares	Defined	2026-05-15
2025-12-31	$25,396	6,349	-11.1%	Shares	Defined	2026-02-17
2025-09-30	$14,355	7,142	-6.4%	Shares	Defined	2025-11-13
2025-06-30	$9,457	7,627	+187.8%	Shares	Defined	2025-08-14
2025-03-31	$3,233	2,650	-80.5%	Shares	Defined	2025-05-12
2024-12-31	$24,413	13,563	+84668.8%	Shares	Defined	2025-02-13
2024-09-30	$81	16	+77.8%	Shares	Defined	2024-11-13
2022-06-30	$27	9	-90.4%	Shares	Defined	2022-08-12
2022-03-31	$788	94	—	Shares	Defined	2022-05-13
No filing history on record for this holder in this stock.